Table 2.

Change in Medication Use Prior and after Public Reporting of Antipsychotic Quality Measures

Dependent Variables: Percentage of Residents Using	Nonreporting Facilities	Additional Change for Reporting Facilities†
		All Reporting Facilities	Low-Use Reporting Facilities	High-Use Reporting Facilities	Test for Difference between Low and High Use (p-value)
Antipsychotics	−1.389*** (0.298)	−0.552* (0.308)	−0.614* (0.329)	−0.489 (0.317)	.5371
Hypnotics	−1.213*** (0.268)	0.613** (0.248)	0.618** (0.259)	0.608** (0.248)	.9247
Anxiolytics	0.059 (0.367)	0.040 (0.412)	0.095 (0.414)	−0.016 (0.437)	.6157
Antidepressants	−0.618 (0.488)	−0.464 (0.472)	−0.574 (0.477)	−0.354 (0.511)	.3950
Psychoactives	−2.041*** (0.492)	0.204 (0.523)	0.416 (0.545)	−0.009 (0.538)	.1614
Antibiotics	−0.012 (0.387)	0.174 (0.341)	0.050 (0.357)	0.298 (0.351)	.1304

Note. Change in pre-post is calculated using a difference-in-difference regression design. Regressions also control for ownership, chain membership, part of a CCRC, facility size, occupancy rate, payer mix, physical acuity, mental health acuity, presence of Alzheimer’s special care unit, nurse staffing levels, presence of mental health services, physician model, and facility fixed effects. All standard errors are adjusted for clustering within the state. The sample size is 40,415 observations.

^†Additional change reflects the additional change in post period for facilities publically reporting antipsychotic quality relative to facilities not reporting. The All column is the total effect for all facilities publically reporting quality, whereas Low- and High-use columns differentiate facilities based on the level of antipsychotic use. The Difference (p-value) column reports the p-value to determine if there is a difference in the change for low- compared to high-use reporting facilities.

^***p < .01

^**p < .05

^*p < .10.